Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Gastroenterology Webinars & Conferences

Asia Pacific & Middle East
Canada

Gastroenterology – 2027

About us

Conference Series is delighted to announce the 21st European Gastroenterology and Therapeutics Congress, scheduled for May 04–05, 2027, in Barcelona, Spain, under the theme “Transforming Digestive Health: From Microbiome Research to Personalized Treatment.”

The congress aims to bring together leading gastroenterologists, hepatologists, physicians, surgeons, researchers, academicians, healthcare professionals, and industry experts from around the world to exchange knowledge, share scientific advancements, and explore emerging developments in gastrointestinal medicine. This international gathering will provide an engaging platform for discussing innovative approaches to digestive health, disease prevention, diagnosis, and treatment.

The scientific program will highlight a broad range of topics, including inflammatory bowel disease, gastrointestinal cancers, liver and pancreatic disorders, digestive microbiome research, advanced endoscopy, gastrointestinal surgery, and emerging therapeutic strategies. Special emphasis will be placed on precision medicine, artificial intelligence in gastroenterology, personalized treatment approaches, and the role of the gut microbiome in understanding and managing digestive disorders.

Through keynote presentations, oral and poster sessions, interactive discussions, and networking opportunities, the congress seeks to encourage scientific collaboration and foster meaningful professional connections. Join us in Barcelona to share your research, gain valuable insights, explore innovative solutions, and contribute to shaping the future of gastroenterology and digestive healthcare.

 

Sessions/Tracks

1. Advances in Gastrointestinal Therapeutics and Precision Medicine: Explore the latest developments in gastrointestinal therapeutics, focusing on innovative treatment strategies, precision medicine, and personalized approaches to digestive healthcare. This session will highlight advances in pharmacological interventions, biologic therapies, targeted drug delivery, and emerging therapeutic technologies for managing complex gastrointestinal conditions. Discussions will address the integration of molecular diagnostics, genetic profiling, and patient-specific treatment approaches to improve therapeutic outcomes. Researchers and clinicians will examine evolving treatment protocols, clinical trial findings, and future directions in developing safer and more effective therapies for gastrointestinal diseases.

Sub-tracks: Novel Drug Therapies, Biologics, and Targeted Treatment Approaches | Precision Medicine and Personalized Gastrointestinal Care | Emerging Therapeutic Technologies and Clinical Trials

2. Gut Microbiome, Microbiota Research, and Digestive Health: Discover the expanding role of the gut microbiome in maintaining digestive health and influencing gastrointestinal diseases. This session will explore the complex interactions between intestinal microorganisms, immune responses, metabolism, and host health. Particular attention will be given to microbiome diversity, dysbiosis, probiotics, prebiotics, and fecal microbiota transplantation. Discussions will also examine the relationship between gut microbiota and inflammatory bowel disease, colorectal cancer, metabolic disorders, and functional gastrointestinal conditions. Researchers will share emerging findings and therapeutic opportunities involving microbiome-based interventions and personalized digestive healthcare.

Sub-tracks: Gut Microbiota Diversity, Dysbiosis, and Host–Microbe Interactions | Probiotics, Prebiotics, and Fecal Microbiota Transplantation | Microbiome-Based Therapeutics and Precision Digestive Health

3. Advanced Endoscopy, Interventional Gastroenterology, and AI-Assisted Diagnostics: Examine the latest innovations in gastrointestinal endoscopy and minimally invasive diagnostic and therapeutic procedures. This session will focus on advanced imaging technologies, artificial intelligence-assisted endoscopic screening, and interventional techniques that are transforming gastrointestinal practice. Topics will include endoscopic ultrasound, endoscopic retrograde cholangiopancreatography, endoscopic mucosal resection, and submucosal dissection. Experts will discuss the role of advanced endoscopic procedures in early disease detection, cancer management, and therapeutic intervention, alongside technological developments that improve diagnostic accuracy, procedural safety, and patient outcomes.

Sub-tracks: Advanced Diagnostic and Therapeutic Endoscopy Techniques | Artificial Intelligence, Image Enhancement, and Computer-Aided Endoscopy | ERCP, Endoscopic Ultrasound, and Minimally Invasive Interventions

4. Inflammatory Bowel Disease (IBD): Crohn’s Disease, Ulcerative Colitis, and Emerging Therapies: Explore current advances in understanding, diagnosing, and treating inflammatory bowel diseases, particularly Crohn’s disease and ulcerative colitis. This session will address disease mechanisms, genetic susceptibility, immune dysregulation, environmental factors, and the role of intestinal microbiota in IBD development. Discussions will highlight emerging biologics, small-molecule therapies, personalized treatment strategies, and advanced diagnostic biomarkers. Special attention will be given to disease monitoring, treatment resistance, surgical management, and long-term patient outcomes. Researchers and clinicians will examine innovative approaches to achieving sustained remission and improving quality of life.

Sub-tracks: Crohn’s Disease and Ulcerative Colitis: Diagnosis and Management | Biologics, JAK Inhibitors, and Emerging IBD Therapeutics | IBD Biomarkers, Disease Monitoring, and Personalized Treatment

5. Hepatology and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD/MASH): Highlight recent developments in hepatology, focusing on the prevention, diagnosis, and management of acute and chronic liver diseases. This session will explore metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction-associated steatohepatitis (MASH), viral hepatitis, autoimmune liver disorders, and other emerging hepatological challenges. Discussions will cover non-invasive diagnostic techniques, liver fibrosis assessment, molecular biomarkers, and innovative pharmacological interventions. Experts will also examine the relationship between metabolic health, obesity, diabetes, and liver disease, alongside emerging therapeutic strategies aimed at preventing disease progression and improving liver health.

Sub-tracks: MASLD/MASH: Pathogenesis, Diagnosis, and Emerging Treatments | Viral Hepatitis, Autoimmune Hepatitis, and Chronic Liver Disorders | Liver Fibrosis, Non-Invasive Assessment, and Novel Therapeutics

6. Gastrointestinal Oncology: Early Detection, Molecular Diagnostics, and Targeted Therapies: Focus on emerging developments in gastrointestinal oncology, including the prevention, early diagnosis, and treatment of cancers affecting the digestive system. This session will cover colorectal, gastric, esophageal, pancreatic, and hepatobiliary cancers, emphasizing molecular profiling, genetic biomarkers, and precision oncology. Discussions will explore immunotherapy, targeted drug treatments, liquid biopsies, and minimally invasive diagnostic approaches. Particular attention will be given to early cancer screening, personalized therapeutic strategies, multidisciplinary cancer management, and advances in clinical research that are transforming outcomes for patients with gastrointestinal malignancies.

Sub-tracks: Colorectal, Gastric, and Esophageal Cancer: Screening and Diagnosis | Pancreatic and Hepatobiliary Oncology: Emerging Therapeutic Approaches | Immunotherapy, Molecular Profiling, and Precision Cancer Treatment

7. Pancreaticobiliary Disorders: Pancreatitis, Biliary Diseases, and Emerging Interventions: Explore the latest clinical and research developments in pancreatic and biliary disorders, including acute and chronic pancreatitis, pancreatic neoplasms, gallstone disease, and bile duct abnormalities. This session will examine disease mechanisms, diagnostic imaging, biomarkers, and advanced interventional procedures. Discussions will highlight developments in endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), minimally invasive pancreatic interventions, and multidisciplinary treatment approaches. Researchers and clinicians will also address emerging therapeutic strategies, complications, and innovations aimed at improving diagnosis, disease management, and long-term outcomes in pancreaticobiliary healthcare.

Sub-tracks: Acute and Chronic Pancreatitis: Diagnosis and Therapeutic Management | Biliary Tract Disorders, Gallstones, and Cholangiocarcinoma | Advanced Pancreaticobiliary Endoscopy and Minimally Invasive Interventions

8. Functional Gastrointestinal Disorders, IBS, and Gut–Brain Interaction: Examine the evolving understanding of functional gastrointestinal disorders and disorders of gut–brain interaction, including irritable bowel syndrome (IBS), functional dyspepsia, and chronic abdominal pain. This session will explore the influence of gastrointestinal motility, visceral hypersensitivity, intestinal microbiota, psychological factors, and neurological pathways on digestive function. Discussions will highlight advances in diagnostic criteria, dietary interventions, pharmacological treatments, and behavioral therapies. Special emphasis will be placed on multidisciplinary management, emerging research, and personalized approaches to improving symptom control and quality of life.

Sub-tracks: Irritable Bowel Syndrome and Functional Dyspepsia | Gut–Brain Axis, Visceral Hypersensitivity, and Gastrointestinal Motility | Dietary, Pharmacological, and Behavioral Treatment Strategies

9. Gastrointestinal Infections, H. pylori, and Antimicrobial Resistance: Address emerging challenges and scientific advances in the diagnosis, prevention, and treatment of gastrointestinal infections. This session will explore bacterial, viral, parasitic, and fungal infections affecting the digestive system, with particular attention to Helicobacter pylori, antibiotic resistance, and emerging infectious threats. Discussions will cover molecular diagnostic techniques, antimicrobial stewardship, infection prevention, and innovative treatment strategies. Researchers and healthcare professionals will examine the impact of resistant pathogens, advances in microbiological testing, and new therapeutic approaches to managing gastrointestinal infections and reducing associated complications.

Sub-tracks: Helicobacter pylori Infection: Diagnosis, Eradication, and Resistance | Bacterial, Viral, and Parasitic Gastrointestinal Infections | Antimicrobial Resistance, Molecular Diagnostics, and Infection Control

10. Pediatric Gastroenterology, Nutrition, and Intestinal Disorders: Explore advances in the diagnosis and management of gastrointestinal and nutritional disorders affecting infants, children, and adolescents. This session will address pediatric inflammatory bowel disease, celiac disease, food allergies, gastrointestinal infections, intestinal motility disorders, and childhood liver diseases. Discussions will highlight the importance of early diagnosis, nutritional interventions, growth monitoring, and age-specific therapeutic strategies. Special attention will be given to emerging diagnostic technologies, pediatric microbiome research, and multidisciplinary approaches to managing complex digestive conditions while supporting healthy growth, development, and long-term wellbeing.

Sub-tracks: Pediatric Inflammatory Bowel Disease and Intestinal Disorders | Nutrition, Food Allergies, and Celiac Disease | Pediatric Liver Diseases, Gut Microbiome, and Therapeutic Advances

11. Cirrhosis, Portal Hypertension, and Liver Transplantation: Discuss current advances in the management of advanced liver diseases, with particular emphasis on liver cirrhosis, portal hypertension, and liver transplantation. This session will explore the mechanisms of liver fibrosis, disease progression, and complications such as ascites, hepatic encephalopathy, and variceal bleeding. Topics will include non-invasive liver assessment, advanced imaging, innovative treatment approaches, and transplant-related developments. Experts will also examine transplant eligibility, post-transplant care, immunosuppressive therapies, and emerging strategies for improving survival, preventing complications, and enhancing the quality of life of patients with end-stage liver disease.

Sub-tracks: Liver Cirrhosis, Fibrosis, and Portal Hypertension Management | Hepatic Encephalopathy, Ascites, and Variceal Bleeding | Liver Transplantation, Immunosuppression, and Post-Transplant Care

12. Celiac Disease, Food Intolerance, and Nutritional Approaches to Digestive Health: Explore the relationship between nutrition, immune responses, and gastrointestinal health, focusing on celiac disease, food intolerances, and diet-related digestive disorders. This session will examine the genetic and immunological mechanisms underlying celiac disease, advances in diagnostic testing, and the management of gluten-related conditions. Discussions will also address non-celiac gluten sensitivity, lactose intolerance, nutritional deficiencies, and the role of personalized dietary interventions in digestive healthcare. Researchers and clinicians will explore emerging nutritional therapies, dietary assessment approaches, and evidence-based strategies for improving intestinal health and patient wellbeing.

Sub-tracks: Celiac Disease: Immunopathogenesis, Diagnosis, and Management | Food Intolerances, Gluten Sensitivity, and Dietary Disorders | Nutritional Therapy, Gut Health, and Personalized Dietary Interventions

Market Analysis

The global gastroenterology market is expanding steadily, driven by rising gastrointestinal (GI) disorders, aging populations, preventive screening demand, and advances in diagnostics and biologics. Market estimates vary by scope (drugs, devices, diagnostics, or full healthcare spend), with recent projections placing the broader market around US$34.1 billion to US$69.08 billion in 2025–2026 and growing at roughly 5.7% to 7.34% CAGR.

Broader Gastroenterology Market: Valued at US$34.1 billion in 2025 and projected to reach US$50.3 billion by 2032 (5.7% CAGR), while other scope definitions estimate US$69.08 billion in 2026 toward US$130.64 billion by 2035 (7.34% CAGR).

Emerging research in gut microbiome science, precision medicine, biologics, and personalized treatment approaches is creating new opportunities for clinical research and pharmaceutical development. Healthcare institutions and biotechnology companies are increasingly investing in innovative solutions to improve patient outcomes and address complex gastrointestinal conditions.

The 21st European Gastroenterology and Therapeutics Congress 2027 will provide an international platform for researchers, clinicians, healthcare professionals, and industry leaders to exchange expertise, explore emerging market trends, establish collaborations, and discuss future opportunities shaping digestive healthcare.

Past Conference Report

The previous edition of the Gastroenterology Conference was successfully conducted as a webinar on November 18, 2026, bringing together gastroenterologists, physicians, researchers, academicians, and healthcare professionals from different parts of the world.

The virtual event provided an interactive platform for sharing scientific knowledge, discussing recent advancements, and exploring emerging developments in digestive health and gastrointestinal medicine.

The programme featured insightful presentations and discussions covering gastrointestinal disorders, hepatology, endoscopic innovations, inflammatory bowel disease, digestive therapeutics, and clinical research. Participants had the opportunity to exchange perspectives, gain valuable scientific insights, and establish professional connections.

The successful completion of the webinar reflected the growing importance of international collaboration and knowledge exchange in advancing gastroenterology and digestive healthcare.

To Collaborate Scientific Professionals around the World

Conference Date May 04-05, 2027

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Supported By

Journal of Hepatology and Gastrointestinal disorders Research and Reports in Gastroenterology

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by